Celiac disease markers in patients with liver diseases: A single center large scale screening study

Table 3 Patients with liver disease newly diagnosed with celiac disease

No.	Age	Gender	Diagnosis	Liver histology
1	34	F	PSC	Portal tracts with ductular reaction and minimal inflammation, features of chronic cholestasis
2	37	M	PSC	Florid ductular reaction with accompanying mild mixed inflammation and focal dark-brown granules of copper-associated protein (in orcein stain) in periportal hepatocytes
3	33	M	Wilson's d.	Macrovesicular steatosis, periportal fibrosis and periportal hepatocytes with glycogenated nuclei
4	35	F	Wilson's d.	Focal steatosis, periportal and septal fibrosis
5	36	F	Wilson's d.	Mild nonspecific hepatocellular injury with spotty hepatocyte necrosis and mononuclear portal
				inflammatory infiltrate, scattered apoptotic bodies and mild steatosis
6	29	M	AIH type I	Portal and lobular inflammation, periportal fibrosis
7	33	F	AIH type I	Portal and periportal inflammation, spotty necrosis
8	33	F	AIH type I	Chronic hepatitis pattern of injury with portal-based inflammation and fibrosis
9	40	F	AIH type I	Periportal interface activity and scattered hepatocyte necrosis
10	35	F	PBC	Bile duct injury with epithelioid granuloma, portal inflammation
11	32	M	Toxic hepatitis	Portal inflammation with scattered eosinophils, spotty necrosis
12	50	F	Budd-Chiari s.	Extensive centrilobular necrosis of hepatocytes
13	22	M	Celiac hepatitis	Non-specific reactive hepatitis with mild portal inflammation
14	27	M	Celiac hepatitis	Mild lobular inflammation with apoptotic bodies and hepatocyte necrosis
15	50	F	Celiac hepatitis	Mild periportal fibrosis with mild portal inflammation and focal interface activity
16	40	F	NASH	Ballooned hepatocytes, macrovesicular steatosis accentuated in zone 3 without significant liver injury

No.: Number; F: Female; M: Male; d.: Disease; PBC: Primary biliary cirrhosis; s.: Syndrome; NASH: Non–alcoholic steatohepatitis; PSC: Primary sclerosing cholangitis; AIH: Autoimmune hepatitis.